We founded the Swiss Ventures Group because the wealth of experience we have accumulated over the years is meant to be shared. Check out our news and find extensive background information on investments, startups and the world of VC.
Venturelab has interviewed Maël Fabien, founder of our Serpentine Ventures portfolio company Biped. As part of the Swiss National Medtech Team 2023, Biped is set to unveil its revolutionary AI copilot innovation to investors in Boston.
Our Serpentine Ventures portfolio companies, Properti AG, Isochronic AG and Auxivo AG were recognized as being part of the TOP 100 Swiss Startup Awards 2023. Congratulations and we remain committed to supporting their continued success.
Piomic, our Swiss Diabetes Venture Fund portfolio company, enrolls first patients in MAVERICKS U.S. study after Medicare Category B designation. FDA-approved IDE study sets groundwork for device authorization and commercialization.
Discover the insights in Partners Group's white paper: Private Markets - The New Traditional Asset Class. Explore how private and public markets are redefining the role of financing in the real economy.